The German Alzheimer Association (Deutsche Alzheimer Gesellschaft e.V. Selbsthilfe Demenz, DAlzG) and the DZNE aim to develop joint information services for dementia patients and their families. As World Alzheimer’s Day approaches on September 21st, the two…

Prof. Adriano Aguzzi of the University of Zurich (Switzerland) and Prof. Charles Weissmann of the Scripps Research Institute Florida (USA) will be awarded the 2013 “Hartwig Piepenbrock-DZNE Prize” for outstanding research in the field of neurodegenerative…

Prof. Thomas Wolbers from the Magdeburg site of the DZNE has been awarded a “Starting Grant” from the European Research Council (ERC) and thus, the support of one of Europe’s most prestigious funding programs. He will receive around 1.3 million Euros for a…

4th DZNE/Gladstone Workshop 11-13 May 2014, Bonn, Germany Cell and Organ Interactions in the Pathogenesis of Neurodegenerative Diseases The Gladstone Institute of Neurological Disease (GIND) and DZNE co-organize an annual workshop addressing the latest…

The drug rapamycin is known to increase lifespan in mice. Whether rapamycin slows down aging, however, remains unclear. A team of researchers from the s DZNE has now found that rapamycin extends lifespan - but its impact on aging itself is limited. The…

In the current issue of Science Translational Medicine, Luís Maia and Stephan Kaeser from the Hertie Institute for Clinical Brain Research at the University of Tübingen and the German Center for Neurodegenerative Diseases report, together with colleagues from…

The U.S. Alzheimer's Association honors Dr. Eva-Maria Mandelkow and Prof. Dr. Eckhard Mandelkow from the German Center for Neurodegenerative Diseases (DZNE) and the caesar research center.

The Dutch molecular biologist Peter Heutink (52) is the new Site Speaker for the DZNE in Tübingen. He specializes in the genetic causes of neurodegenerative diseases. Prof. Heutink is succeeding Prof. Thomas Gasser in this capacity.

U.S. university honors achievements in neurodegenerative disease research

In Parkinson’s disease, the protein “alpha-synuclein” aggregates and accumulates within neurons. The mechanism underlying this pathological progression is poorly understood. Scientists at the DZNE in Bonn have developed a novel experimental model that reproduces…